PL3568403T3 - Związki chemiczne do powlekania nanostruktur - Google Patents

Związki chemiczne do powlekania nanostruktur

Info

Publication number
PL3568403T3
PL3568403T3 PL18700364T PL18700364T PL3568403T3 PL 3568403 T3 PL3568403 T3 PL 3568403T3 PL 18700364 T PL18700364 T PL 18700364T PL 18700364 T PL18700364 T PL 18700364T PL 3568403 T3 PL3568403 T3 PL 3568403T3
Authority
PL
Poland
Prior art keywords
nanostructures
coating
chemical compounds
compounds
chemical
Prior art date
Application number
PL18700364T
Other languages
English (en)
Inventor
Oskar Axelsson
Angelo Sanzone
Original Assignee
Spago Nanomedical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spago Nanomedical Ab filed Critical Spago Nanomedical Ab
Publication of PL3568403T3 publication Critical patent/PL3568403T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A61K49/1833Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with a small organic molecule
    • A61K49/1848Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with a small organic molecule the small organic molecule being a silane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32Polymers modified by chemical after-treatment
    • C08G65/329Polymers modified by chemical after-treatment with organic compounds
    • C08G65/336Polymers modified by chemical after-treatment with organic compounds containing silicon
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/49Phosphorus-containing compounds
    • C08K5/51Phosphorus bound to oxygen
    • C08K5/53Phosphorus bound to oxygen bound to oxygen and to carbon only
    • C08K5/5317Phosphonic compounds, e.g. R—P(:O)(OR')2
    • C08K5/5333Esters of phosphonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nanotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Silicon Polymers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Paints Or Removers (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Polyethers (AREA)
PL18700364T 2017-01-16 2018-01-16 Związki chemiczne do powlekania nanostruktur PL3568403T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17151653.7A EP3348560A1 (en) 2017-01-16 2017-01-16 Chemical compounds for coating of nanostructures
EP18700364.5A EP3568403B1 (en) 2017-01-16 2018-01-16 Chemical compounds for coating of nanostructures
PCT/EP2018/050975 WO2018130713A1 (en) 2017-01-16 2018-01-16 Chemical compounds for coating of nanostructures

Publications (1)

Publication Number Publication Date
PL3568403T3 true PL3568403T3 (pl) 2021-11-08

Family

ID=57799639

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18700364T PL3568403T3 (pl) 2017-01-16 2018-01-16 Związki chemiczne do powlekania nanostruktur

Country Status (15)

Country Link
US (1) US11401376B2 (pl)
EP (2) EP3348560A1 (pl)
JP (1) JP7078274B2 (pl)
KR (1) KR102536477B1 (pl)
CN (1) CN110191890B (pl)
AU (1) AU2018208538B2 (pl)
BR (1) BR112019014483B1 (pl)
CA (1) CA3048552A1 (pl)
DK (1) DK3568403T3 (pl)
ES (1) ES2880228T3 (pl)
IL (1) IL267895B2 (pl)
PL (1) PL3568403T3 (pl)
RU (1) RU2757904C2 (pl)
WO (1) WO2018130713A1 (pl)
ZA (1) ZA201904405B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7233912B2 (en) 1997-08-26 2007-06-19 Walker Digital, Llc Method and apparatus for vending a combination of products
TWI644942B (zh) * 2015-06-12 2018-12-21 日商大金工業股份有限公司 表面處理劑
EP3838967A1 (en) * 2019-12-16 2021-06-23 Spago Nanomedical AB Immobilization of phenolic compounds
CN114015036A (zh) * 2021-11-01 2022-02-08 三棵树(上海)新材料研究有限公司 低粘度硅烷改性聚醚树脂及其制备方法
EP4242250A1 (en) 2022-03-08 2023-09-13 Spago Nanomedical AB Compounds for coating of nanostructures
EP4241792A1 (en) * 2022-03-08 2023-09-13 Spago Nanomedical AB Nanostructures and applications thereof
EP4241765A1 (en) * 2022-03-08 2023-09-13 Spago Nanomedical AB Globular nanostructures having an anchoring layer
EP4241793A1 (en) * 2022-03-08 2023-09-13 Spago Nanomedical AB Globular nanostructures
CN116608891B (zh) * 2023-07-20 2023-11-03 山东省科学院激光研究所 一种光纤f-p腔传感器及其制造方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6310243B1 (en) 1994-09-23 2001-10-30 Nycomed Imaging As Iodinated x-ray contrast media
AU2006284565B2 (en) * 2005-09-02 2013-05-30 Visen Medical, Inc. Biocompatible N, N-disubstituted sulfonamide-containing fluorescent dye labels
EP2272897B1 (en) * 2008-03-10 2016-12-28 The University of Tokyo Copolymer including uncharged hydrophilic block and cationic polyamino acid block having lateral chain to which hydrophobic radical is partially introduced, and use of copolymer
KR20110075029A (ko) * 2008-10-21 2011-07-05 엔즌 파마슈티칼스, 인코포레이티드 7-에틸-10-하이드록시캄토테신의 다중-암 고분자 컨쥬게이트로 신경모세포종의 치료
KR101252063B1 (ko) * 2011-08-25 2013-04-12 한국생산기술연구원 알콕시실릴기를 갖는 에폭시 화합물, 이의 제조 방법, 이를 포함하는 조성물과 경화물 및 이의 용도
EP2572736A1 (en) 2011-09-23 2013-03-27 Spago Imaging AB Nanostructures comprising manganese
WO2013137663A1 (ko) * 2012-03-14 2013-09-19 한국생산기술연구원 알콕시실릴기를 갖는 에폭시 화합물, 이를 포함하는 조성물, 경화물, 이의 용도 및 알콕시실릴기를 갖는 에폭시 화합물의 제조방법
EP2857436B1 (en) * 2012-05-31 2019-10-09 Kaneka Corporation Polymer having terminal structure including plurality of reactive silicon groups, method for manufacturing same, and use for same
KR101520764B1 (ko) * 2012-06-01 2015-05-15 한국생산기술연구원 알콕시실릴기를 갖는 에폭시 화합물, 무기입자를 포함하는 조성물, 경화물, 이의 용도 및 알콕시실릴기를 갖는 에폭시 화합물의 제조방법
NZ705910A (en) * 2012-10-12 2018-09-28 Medimmune Ltd Pyrrolobenzodiazepines and conjugates thereof
WO2014057120A1 (en) * 2012-10-12 2014-04-17 Adc Therapeutics Sàrl Pyrrolobenzodiazepine-antibody conjugates
KR101755323B1 (ko) * 2014-02-19 2017-07-20 한국생산기술연구원 신규한 에폭시 화합물, 이를 포함하는 혼합물, 조성물, 경화물, 이의 제조 방법, 및 이의 용도
EP2923712A1 (en) 2014-03-28 2015-09-30 Spago Imaging AB Nanostructures and applications thereof
CN104530417B (zh) * 2014-10-01 2017-09-08 厦门赛诺邦格生物科技股份有限公司 一种多官能化h型聚乙二醇衍生物及其制备方法
US11324827B2 (en) * 2014-10-01 2022-05-10 Xiamen Sinopeg Biotech Co., Ltd. Multifunctionalized polyethylene glycol derivative and preparation method therefor
EP3464789B1 (en) * 2016-06-07 2021-04-28 Welltec A/S Downhole operational tool

Also Published As

Publication number Publication date
US20190352459A1 (en) 2019-11-21
AU2018208538B2 (en) 2021-05-20
BR112019014483A2 (pt) 2020-02-11
CN110191890B (zh) 2022-11-15
CA3048552A1 (en) 2018-07-19
RU2757904C2 (ru) 2021-10-22
EP3568403B1 (en) 2021-04-21
KR20190104598A (ko) 2019-09-10
BR112019014483B1 (pt) 2023-01-17
ES2880228T3 (es) 2021-11-24
IL267895A (en) 2019-09-26
RU2019125812A (ru) 2021-02-16
RU2019125812A3 (pl) 2021-05-12
CN110191890A (zh) 2019-08-30
DK3568403T3 (da) 2021-07-12
WO2018130713A1 (en) 2018-07-19
EP3348560A1 (en) 2018-07-18
ZA201904405B (en) 2022-09-28
JP2020507559A (ja) 2020-03-12
KR102536477B1 (ko) 2023-05-25
AU2018208538A1 (en) 2019-07-18
JP7078274B2 (ja) 2022-05-31
IL267895B (en) 2022-12-01
EP3568403A1 (en) 2019-11-20
IL267895B2 (en) 2023-04-01
US11401376B2 (en) 2022-08-02

Similar Documents

Publication Publication Date Title
IL267895A (en) Chemical compounds for the coating of nanostructures
IL273769A (en) chemical compounds
GB201609602D0 (en) Chemical compounds
GB201604680D0 (en) Chemical Compounds
GB201604681D0 (en) Chemical Compounds
HK1244497A1 (zh) 用於塗佈製品的方法
GB201604589D0 (en) Chemical compound
ZA202000529B (en) Chemical compounds
GB201614934D0 (en) Chemical compounds
GB201708203D0 (en) Chemical compounds
ZA201906035B (en) Chemical compounds
IL268835B (en) A process for the preparation of 2-cyanoimidazole compounds
GB201704476D0 (en) Chemical compounds
GB201602527D0 (en) Chemical compounds
GB201720989D0 (en) Chemical compounds
IL275480A (en) A process for the preparation of pyrimidinyl-4-aminopyrazole compounds
GB2554032B (en) Method of Coating
GB201706102D0 (en) Chemical compounds
GB201614940D0 (en) Chemical compounds
GB201712081D0 (en) Chemical compounds
GB201709317D0 (en) Chemical Compounds
GB201705891D0 (en) Chemical compounds
GB201703021D0 (en) Chemical compounds
GB201622002D0 (en) Chemical compounds
AU2016902705A0 (en) Coating compounds